Intellectual
property strategy
| Commercialization of biomedical discoveries requires strong intellectual property. Investors need the confidence that the multi-million dollar investments will provide economic returns at the end of what is often a 5-10 year development horizon for new diagnostics and therapeutics. |
CGDN Management works closely with investigators and university/hospital partners, who retain ownership of intellectual property developed, to create robust intellectual property positions which can underpin commercial activities.
The teams formed by the Network concentrate on filing patents early to optimize the downstream commercial benefits from Network research. The Network shares in added-value created by these efforts through the sharing of ultimate royalty flows, or by taking equity stakes in new ventures.
